gemcitabine has been researched along with transforming growth factor alpha in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lavi, S; Leitner, O; Lindzen, M; Yarden, Y | 1 |
1 other study(ies) available for gemcitabine and transforming growth factor alpha
Article | Year |
---|---|
Tailored cancer immunotherapy using combinations of chemotherapy and a mixture of antibodies against EGF-receptor ligands.
Topics: Animals; Antibodies; Antibodies, Monoclonal; Antibody Specificity; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; ErbB Receptors; Female; Gemcitabine; Heparin-binding EGF-like Growth Factor; Humans; Immunotherapy; Intercellular Signaling Peptides and Proteins; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms; Pancreatic Neoplasms; Transforming Growth Factor alpha | 2010 |